Zentalis Pharmaceuticals Llc (ZNTL)
Healthcare
Biotechnology
4.70 $
-1.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Zentalis Pharmaceuticals Llc (ZNTL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -33 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -79 | -39 | -41 | -52 | -35 | -44 | -40 | -33 | -35 | -27 | -31 | -33 | -126 | |
| 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.6 | |
| 13 | 14 | 14 | 13 | 13 | 10 | 31 | 6.5 | 6.3 | 4.8 | 3.1 | 3.2 | 17 | |
| 26 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -5.2 | 4.8 | 10 | -16 | 14 | -7.3 | -4.5 | 1.8 | -8.3 | -1.2 | -1.4 | -0.7 | -12 | |
| 0.3 | 0.1 | 0.2 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 73 | -117 | -42 | 62 | 34 | 48 | 32 | 40 | 30 | 28 | 32 | 30 | 121 | |
| 237 | – | – | -0.2 | – | 0.2 | – | – | – | – | – | – | – | |
| 237 | 0.3 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.2 | 0.0 | 0.1 | -4.6 | -1.1 | -5.6 | |
| 230 | -156 | -83 | 9.6 | -0.6 | 4.3 | -7.4 | 8.0 | -4.3 | 1.5 | -3.1 | -4.1 | -10.0 | |
| -80 | -39 | -41 | -52 | -35 | -44 | -40 | -33 | -35 | -27 | -31 | -33 | -126 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.